Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -118,869 | -57,647 | -187,091 | -134,415 | -81,475 |
| Depreciation Amortization | 5,299 | 2,938 | 10,344 | 7,390 | 4,746 |
| Accounts receivable | 305 | 546 | 464 | -1,019 | -134 |
| Accounts payable and accrued liabilities | -1,444 | -492 | 2,239 | -334 | -523 |
| Other Working Capital | -12,067 | -7,114 | 8,724 | 4,479 | -3,298 |
| Other Operating Activity | 15,900 | 6,609 | 18,140 | 15,984 | 9,357 |
| Operating Cash Flow | $-110,876 | $-55,160 | $-147,180 | $-107,915 | $-71,327 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 110,841 | 45,914 | -135,589 | -145,305 | -115,582 |
| PPE Investments | -4,415 | -1,889 | -6,528 | -5,345 | -4,891 |
| Investing Cash Flow | $106,426 | $44,025 | $-142,117 | $-150,650 | $-120,473 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,734 | 305 | 294,603 | 283,451 | 283,132 |
| Other Financing Activity | 0 | 0 | -424 | 0 | 0 |
| Financing Cash Flow | $1,734 | $305 | $294,179 | $283,451 | $283,132 |
| Beginning Cash Position | 110,234 | 110,234 | 105,352 | 105,352 | 105,352 |
| End Cash Position | 107,518 | 99,404 | 110,234 | 130,238 | 196,684 |
| Net Cash Flow | $-2,716 | $-10,830 | $4,882 | $24,886 | $91,332 |
| Free Cash Flow | |||||
| Operating Cash Flow | -110,876 | -55,160 | -147,180 | -107,915 | -71,327 |
| Capital Expenditure | -4,415 | -1,889 | -6,528 | -5,345 | -4,891 |
| Free Cash Flow | -115,291 | -57,049 | -153,708 | -113,260 | -76,218 |